Comparative mirna expression profiles in individuals with latent and active tuberculosis

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Wang, Chuan ^a   Yang, Shunyao ^a   Sun, Gang ^a   Tang, Xuying ^b   Lu, Shuihua ^b   Neyrolles, Olivier ^c   Gao, Qian ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI PUBLIC HEALTH CLINICAL CENTER   (China)

^c INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; TRANSCRIPTOME;

ADOLESCENT; ADULT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE REGULATORY NETWORK; GENE TARGETING; HUMAN; HUMAN CELL; KIDNEY TUBERCULOSIS; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN RNA BINDING; RNA TRANSCRIPTION; TUBERCULOSIS; TUBERCULOUS LYMPHADENITIS; CASE CONTROL STUDY; COMPARATIVE STUDY; DNA MICROARRAY; GENETICS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; CASE-CONTROL STUDIES; GENE REGULATORY NETWORKS; HUMANS; LATENT TUBERCULOSIS; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 80053931516     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025832     Document Type: Article

References (40)

1. World Health Organization (2009) WHO Report 2009: Global Tuberculosis Control. Epidemiology, Strategy, Financing.
2. Kaufmann SH, McMichael AJ, (2005) Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med 11: S33-44.
3. Barry CE, Boshoff HI, Dartois V, Dick T, Ehrt S, et al. (2009) The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nature Reviews Microbiology 7: 845-855.
4. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis- Global trends and interactions with the HIV epidemic. Archives of Internal Medicine 163: 1009-1021.
5. Verver S, Warren RM, Munch Z, Vynnycky E, van Helden PD, et al. (2004) Transmission of tuberculosis in a high incidence urban community in South Africa. International Journal of Epidemiology 33: 351-357.
6. Selwyn PA, (1993) Clinical Manifestations and Predictors of Disease Progression in Drug-Users with Human-Immunodeficiency-Virus Infection (Vol 327, Pg 327, 1992). New England Journal of Medicine 328: 671-671.
7. Lin PL, Flynn JL, (2010) Understanding latent tuberculosis: a moving target. J Immunol 185: 15-22.
8. Casanova JL, Abel L, (2002) Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 20: 581-620.
9. Chao MC, Rubin EJ, (2010) Letting Sleeping dos Lie: Does Dormancy Play a Role in Tuberculosis? Annual Review of Microbiology Vol 64, 2010 64: 293-311.
10. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, et al. (2007) Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. Journal of Molecular Medicine-Jmm 85: 613-621.
11. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, et al. (2011) Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes and Immunity 12: 15-22.
12. Berry MPR, Graham CM, McNab FW, Xu ZH, Bloch SAA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-U998.
13. Harari A, Rozot V, Enders FB, Perreau M, Stalder JM, et al. (2011) Dominant TNF-alpha(+) Mycobacterium tuberculosis-specific CD4(+) T cell responses discriminate between latent infection and active disease. Nature Medicine 17: 372-U174.
14. Bartel DP, (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
15. Coolen M, Bally-Cuif L, (2009) MicroRNAs in brain development and physiology. Current Opinion in Neurobiology 19: 461-470.
16. Ivey KN, Srivastava D, (2010) MicroRNAs as Regulators of Differentiation and Cell Fate Decisions. Cell Stem Cell 7: 36-41.
17. Bailey SG, Sanchez-Elsner T, Stephanou A, Cragg MS, Townsend PA, (2010) Regulating the genome surveillance system: miRNAs and the p53 super family. Apoptosis 15: 541-552.
18. Dykxhoorn DM, (2010) MicroRNAs and Metastasis: Little RNAs Go a Long Way. Cancer Research 70: 6401-6406.
19. Skalsky RL, Cullen BR, (2010) Viruses, microRNAs, and Host Interactions. Annual Review of Microbiology Vol 64, 2010 64: 123-141.
20. Iorio MV, Croce CM, (2009) MicroRNAs in Cancer: Small Molecules With a Huge Impact. Journal of Clinical Oncology 27: 5848-5856.
21. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD, (2008) MicroRNAs: new regulators of immune cell development and function. Nature Immunology 9: 839-845.
22. Lodish HF, Zhou BY, Liu G, Chen CZ, (2008) Micromanagement of the immune system by microRNAs (vol 8, pg 120, 2008). Nature Reviews Immunology 8: 238-238.
23. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, et al. (2009) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327: 198-201.
24. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435 (7043): 834-8.
25. Pankla R, Buddhisa S, Berry M, Blankenship DM, Bancroft GJ, et al. (2009) Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biology 10: R 127.
26. Zhao Y, Simon R, (2008) BRB-ArrayTools Data Archive for human cancer gene expression: a unique and efficient data sharing resource. Cancer Inform 6: 9-15.
27. Ura S, Honda M, Yamashita T, Ueda T, Takatori H, et al. (2009) Differential MicroRNA Expression Between Hepatitis B and Hepatitis C Leading Disease Progression to Hepatocellular Carcinoma. Hepatology 49: 1098-1112.
28. Wang B, Howel P, Bruheim S, Ju J, Owen LB, et al. (2011) Systematic Evaluation of Three microRNA Profiling Platforms: Microarray, Beads Array, and Quantitative Real-Time PCR Array. PLoS ONE 6 (2): e17167 doi:10.1371.
29. Shalgi R, Lieber D, Oren M, Pilpel Y, (2007) Global and local architecture of the mammalian microRNA-transcription factor regulatory network. Plos Computational Biology 3: 1291-1304.
30. Joung JG, Hwang KB, Nam JW, Kim SJ, Zhang BT, (2007) Discovery of microRNA-mRNA modules via population-based probabilistic learning. Bioinformatics 23: 1141-1147.
31. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, et al. (2008) Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451: 1125-U1111.
32. Rosa A, Ballarino M, Sorrentino A, Sthandier O, De Angelis FG, et al. (2007) The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proceedings of the National Academy of Sciences of the United States of America 104: 19849-19854.
33. Forrest ARR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, et al. (2010) Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 24: 460-466.
34. Rasmussen KD, Simmini S, Abreu-Goodger C, Bartonicek N, Di Giacomo M, et al. (2010) The miR-144/451 locus is required for erythroid homeostasis. Journal of Experimental Medicine 207: 1351-1358.
35. Igarashi K, Ochiai K, Muto A, (2007) Architecture and dynamics of the transcription factor network that regulates B-to-plasma cell differentiation. Journal of Biochemistry 141: 783-789.
36. van Doorn R, Zoutman WH, Dijkman R, de Menezes RX, Commandeur S, et al. (2005) Epigenetic profiling of cutaneous T-cell lymphoma: Promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. Journal of Clinical Oncology 23: 3886-3896.
37. Otake Y, Soundararajan S, Sengupta TK, Kio EA, Smith JC, et al. (2007) Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood 109: 3069-3075.
38. Behar SM, Martin CJ, Booty MG, Nishimura T, Zhao X, et al. (2011) Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunology 4: 279-287.
39. Gan H, Lee J, Ren F, Chen M, Kornfeld H, et al. (2008) Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nat Immunol 9 (10): 1189-97.
40. Zhang J, Jiang R, Takayama H, Tanaka Y, (2005) Survival of virulent Mycobacterium tuberculosis involves preventing apoptosis induced by Bcl-2 upregulation and release resulting from necrosis in J774 macrophages. Microbiol Immunol 49: 845-852.